JNCCN 360 - Prostate - Ongoing CE Activities

Editor:

Sandy Srinivas, MD

Advertisement

Advertisement

Ongoing CE Activities

Active Surveillance for Low-Risk Prostate Cancer Affected by Where Men Live

Applying Personalized Medicine to Oncology Care

Current and Emerging Treatment Options for Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma)

Differentiating GnRH Antagonists From GnRH Agonists: What Are the Latest Data in Prostate Cancer Showing?

MRI With Targeted Biopsy Matches Current Standard for ID'ing Prostate Cancer

Nursing Management of Treatment-Related Side Effects in Metastatic Prostate Cancer

Prostate Cancer — Recent Advances in Medical Oncology

Prostate Cancer Update, Issue 1, 2021

Racial Aspects in Active Surveillance for Low-Risk Prostate Cancer

The Evolving Role of PARP Inhibitors for Cancer Treatment

What Oncology Nurses Need to Know: Role of Hormonal Therapy in the Management of Prostate Cancer

Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Prostate Cancer

Sections

NCCN Resources

Copyright © 2021 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.